Background
Nanxiang (Samuel) Zhao current research focuses on developing a computational method to identify regulatory elements genome-wide utilizing signal processing and machine learning techniques.
Master's student from January 2017 to January 2018
PhD student from January 2018 to May 2023
Bioinformatics Ph.D.
Current: Merck & Co Inc.
Nanxiang (Samuel) Zhao current research focuses on developing a computational method to identify regulatory elements genome-wide utilizing signal processing and machine learning techniques.